kolaviron has been researched along with Prostatic Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajayi, BO; Akinade, AT; Fafioye, AO; Farombi, EO; Opata, EK | 1 |
| Eleazu, C; Ijeh, II; Kalu, WO; Okafor, PN | 1 |
2 other study(ies) available for kolaviron and Prostatic Hyperplasia
| Article | Year |
|---|---|
Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Topics: Animals; Apoptosis; Flavonoids; Humans; Hyperplasia; Male; Plant Extracts; Prostate; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Testosterone; Testosterone Propionate | 2023 |
Effect of kolaviron, a biflavanoid complex from Garcinia kola on some biochemical parameters in experimentally induced benign prostatic hyperplasic rats.
Topics: Animals; Dihydrotestosterone; Estradiol; Flavanones; Flavonoids; Garcinia kola; Male; Plant Extracts; Prostatic Hyperplasia; Rats; Rats, Wistar; Seeds | 2016 |